Loading...
Please wait, while we are loading the content...
Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies.
| Content Provider | Europe PMC |
|---|---|
| Author | Taniguchi, Hiroaki Suzuki, Yasunori Imai, Kohzoh Adachi, Yasushi |
| Page Count | 10 |
| ISSN | 13479032 |
| Volume Number | 113 |
| PubMed Central reference number | PMC9459246 |
| Issue Number | 9 |
| PubMed reference number | 35701833 |
| Journal | Cancer Science [Cancer Sci] |
| e-ISSN | 13497006 |
| DOI | 10.1111/cas.15461 |
| Language | English |
| Publisher | John Wiley and Sons Inc. |
| Publisher Date | 2022-07-11 |
| Publisher Place | Hoboken |
| Access Restriction | Open |
| Rights License | This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. © 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. |
| Subject Keyword | antisense oligonucleotide drug delivery microRNA oligonucleotide therapeutics small interfering RNA |
| Content Type | Text |
| Resource Type | Article |
| Subject | Cancer Research Oncology |